SDC1 and Miyoshi myopathy: Our results showed that after melphalan treatment, the mouse femurs co-injected with MM cells and adipocytes had larger numbers of CD138+ cells; this reflects the MM tumor burdens in these mice, compared with those in mice injected with MM cells alone (Figure 7A).